Lebwohl, M., B. Strober, A. Schrader, A. Li, T. Eckmann, B. Zhu, W. Malatestinic, J. Birt, M. Feely, and A. Blauvelt. “6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry”. SKIN The Journal of Cutaneous Medicine, vol. 7, no. 6, Nov. 2023, p. s232, doi:10.25251/skin.7.supp.232.